Linezolid Injection, Solution
Product Images NDC 63323-713

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Linezolid (NDC 63323-713). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Lin0a 0001 01)

Chemical Structure (Lin0a 0001 01)
Chemical structure of linezolid, showing the specific arrangement of its atoms and bonds consistent with the generic antibiotic molecule.*
FDA Label Image

Figure (Lin0a 0001 02)

Figure (Lin0a 0001 02)
A line graph depicting plasma concentration of Linezolid over time after a 600 mg oral dose every 12 hours. The Y-axis shows Linezolid plasma concentration in µg/mL, ranging from 0 to 28, while the X-axis shows time after dose in hours from 0 to 12. Data points show concentration peaking around 1 hour and then gradually declining over 12 hours with error bars indicating variability.*
FDA Label Image

Fresenius Kabi Logo (Lin0a 0001 03)

FDA Label Image

Bag (Lin0a 0001 04)

Bag (Lin0a 0001 04)
Linezolid Injection, 600 mg per 300 mL (2 mg per mL) solution for intravenous infusion. The label includes directions for use, storage conditions, and warnings. It is manufactured for Fresenius Kabi USA, LLC, Lake Zurich, IL, and made in Norway. The label features barcode and NDC 63323-713-03.*
FDA Label Image

Foilfront (Lin0a 0001 05)

Foilfront (Lin0a 0001 05)
Linezolid Injection 600 mg per 300 mL (2 mg per mL) intravenous infusion solution label. The label includes administration instructions, storage conditions, and warnings. It is manufactured for Fresenius Kabi USA, LLC, made in Norway, with branding for FreeFlex. The container does not contain natural rubber latex and is sterile.*
FDA Label Image

Backfoil (Lin0a 0001 06)

Backfoil (Lin0a 0001 06)
Linezolid Injection label showing strength of 600 mg per 300 mL (2 mg per mL) for intravenous infusion. The label includes 'Rx Only' and has a light blue horizontal band highlighting the strength. Two identical labels are visible on a gray background, each accompanied by a small QR code. No manufacturer name is shown on the label image itself.*
FDA Label Image

Shipper (Lin0a 0001 07)

Shipper (Lin0a 0001 07)
Linezolid Injection 600 mg per 300 mL (2 mg per mL) intravenous solution with a package of 10 vials (300 mL each) from Fresenius Kabi USA, LLC. The label indicates storage at controlled room temperature (20° to 25°C), notes sensitivity to light, and specifies it is made in Norway. The NDC shown is 63323-713-13.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.